project id: TCGA-ACC; case submitter id: TCGA-P6-A5OG; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.94; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.37; rna integrity number: 7.0; age at index: 45; days to birth: -16659; days to death: 383; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1966; year of death: 2012; age at diagnosis: 16659; ajcc clinical m: M1; ajcc pathologic n: N0; ajcc pathologic stage: Stage IV; ajcc pathologic t: T4; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C74.0; last known disease status: not reported; morphology: 8370/3; primary diagnosis: Adrenal cortical carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cortex of adrenal gland; synchronous malignancy: Not Reported; tissue or organ of origin: Cortex of adrenal gland; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 426; days to sample procurement: 0; initial weight: 200.0; portion submitter id: TCGA-P6-A5OG-01A-22; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 8.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 95.0; percent tumor nuclei: 90.0;